AstraZeneca announces positive results for heart drug candidate

World |  News | 0 Comment | 20 Aug, 2019

AstraZeneca, on 20 August 2019, announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met the primary composite endpo...Read more

FDA approves new antibiotic to treat community-acquired bacterial pneumonia

World |  News | 0 Comment | 20 Aug, 2019

The U.S. Food and Drug Administration, on 19 August 2019, approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia. “This new drug provides another op...Read more

Moderna Receives FDA Fast Track Designation for Zika Vaccine

World |  News | 0 Comment | 20 Aug, 2019

Moderna, Inc.,a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, has annou...Read more

Microsoft welcomes new Chief Medical Officer Dr. David Rhew

World |  News | 0 Comment | 20 Aug, 2019

David Rhew, M.D., has joined Microsoft's Worldwide Commercial Business (WCB) Healthcare leadership team as the Chief Medical Officer and Vice President of Healthcare. David joined Microsof...Read more

Boston Scientific Closes Acquisition of BTG plc.

World |  News | 0 Comment | 20 Aug, 2019

Boston Scientific Corporation has announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes pr...Read more

Merck receives 7 additional CRISPR patents, bringing total to 20 worldwide

World |  News | 0 Comment | 20 Aug, 2019

Merck, a leading science and technology company, on 19th August 2019, announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices al...Read more

IDTechEx forecasts $6.1 Billion market for 3D Printed Medical Devices 

World |  News | 0 Comment | 19 Aug, 2019

IDTechEx, a market intelligence and events company focused on emerging technologies, reports that the market for 3D printed medical devices and pharmaceuticals will be worth $6.1 billi...Read more

FDA approves novel treatment for highly drug-resistant forms of TB

World |  News | 0 Comment | 19 Aug, 2019

Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA), on 14 August 2019, for treating some of the...Read more

Medtronic Evolut TAVR System receives expanded indication

World |  News | 0 Comment | 19 Aug, 2019

 Medtronic has announced U.S. Food and Drug Administration (FDA) approval of the EvolutTM Transcatheter Aortic Valve Replacement (TAVR) system for patients with symptoma...Read more

FDA approves novel device to treat idiopathic scoliosis

World |  News | 0 Comment | 19 Aug, 2019

The U.S. Food and Drug Administration has approved the first spinal tether device intended to be used in children and adolescents to correct the most common form of scoliosis, called idiopa...Read more

FDA approves INREBIC for Myelofibrosis treatment

World |  News | 0 Comment | 19 Aug, 2019

Celgene Corporation has announced the U.S. Food and Drug Administration (FDA) has approved INREBIC® (fedratinib) for the treatment of adult patients with intermediate-2 or hig...Read more

AbbVie receives FDA approval for RINVOQ

World |  News | 0 Comment | 19 Aug, 2019

AbbVie,  a research-based global biopharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has approved RINVOQ™ (upadacitinib), a 15 mg, once...Read more

CureVac collaborates with Yale for mRNA-based pulmonary therapeutics

World |  News | 0 Comment | 19 Aug, 2019

CureVac AG, a fully integrated Germany based biopharmaceutical company pioneering the field of mRNA-based drugs, announced that it has entered into a Collaborative Research Agreement (CRA) ...Read more

BioIVT examines link between HIV Integrase inhibitor drugs and NTD during pregnancy

World |  News | 0 Comment | 16 Aug, 2019

BioIVT, a leading provider of research models and services for drug and diagnostic development, on 15 August 2019, announced that researchers in its Transporter Sciences Group have co-autho...Read more

Clinithink and Healthix harness benefits of AI and massive health data

World |  News | 0 Comment | 16 Aug, 2019

Clinithink and Healthix – the largest public health information exchange (HIE) in the U.S. are partnering on a program designed to leverage Healthix clinical data to facilitate t...Read more

Johannesburg gets ready for 5th Healthcare Innovation Summit Africa 2019

World |  News | 0 Comment | 16 Aug, 2019

It is that time of the year again, when healthcare professionals, industry experts and leaders gather to discuss the impact of emerging technologies on their industry. Taking place at the&n...Read more

Roche gets approval for oncology drug, Rozlytrek

World |  News | 0 Comment | 16 Aug, 2019

Genentech, a Roche’s subsidiary announced that the US Food and Drug Administration (FDA) has approved Rozlytrek™ (entrectinib) for the treatment of adults with ROS1-positive, me...Read more

IQVIA to transform clinical trial experience

World |  News | 0 Comment | 16 Aug, 2019

IQVIA announces launch of the IQVIA Patient Portal, a global web-based solution built on a leading health cloud platform. This innovative tool enables increases in clinical trial patient re...Read more